Aβ- participants presented moderate correlations between the different tau indices, but correlations with the other biomarkers (CSF p-tau, SPARE-AD, and florbetapir composite score) were weak or absent (≤0.25). The gene discussed is MAPT; the disease is Alzheimer disease.